Dr Kirsten Coppell
The prevalence of type 1 diabetes is increasing in both children and adults worldwide. Optimising glycaemic control has been shown to reduce microvascular and macrovascular complications in those with type 1 diabetes. However glycaemic control is not always optimal.
International collaboration to compare glycaemic control
Data collected by the Otago Diabetes Project has contributed to a study undertaken as part of an international collaboration to compare glycaemic control among people with type 1 diabetes in different countries.
This collaboration, the International Quality of Care for Type 1 Diabetes Group, is led by Professor John McKnight, the clinical leader of the Scottish Diabetes Group, and Professor Sarah Wild, an epidemiologist at the University of Edinburgh.
Participating countries include Austria, Denmark, England, Finland, France, Germany, Italy, Latvia, New Zealand, Northern Ireland, Norway, Scotland, Slovenia, Sweden, Ukraine, USA, Western Australia.
Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.
McKnight JA, and others. Diabetic Medicine, Dec 15, 2014.
An international collaboration to compare glycaemic control among people with Type 1 diabetes. Presented by John McKnight at the European Association for the Study of Diabetes (EASD). Barcelona, 2013.
Sex differences in glycaemic control among people with Type 1 diabetes.
Presented by Sarah Wild on behalf of the International Quality of Care for Type 1 Diabetes Group (IQoC-T1) at the European Association for the Study of Diabetes (EASD). Barcelona, 2013.